Modulation and Regulation of ROMK Channels in Kidney

肾脏 ROMK 通道的调节和调控

基本信息

  • 批准号:
    8685951
  • 负责人:
  • 金额:
    $ 35.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-03-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): With-No-Lysine Kinase 4 (WNK4) plays an important role in regulating Na and K transport in the aldosterone-sensitive distal nephron (ASDN). Mutation of WNK4 causes familial hyperkalemic hypertension, an autosomal dominant disease characterized by salt-sensitive hypertension, hyperkalemia and renal tubule acidosis (Pseudohypoaldosteronism type II). A large body of evidence shows that WNK4 inhibits ROMK, regulates ENaC and modulates the paracellular Cl permeability in the collecting duct. The inhibitory effect of WNK4 on ROMK is attenuated by serum-glucocorticoid- induced kinase1 (SGK1)-mediated phosphorylation of WNK4 in the "switch-domain". Recently, we have further demonstrated that Src-family protein tyrosine kinases (SFK), such as c-Src, phosphorylates WNK4 and diminishes SGK1-induced phosphorylation of WNK4 thereby restoring the inhibitory effect of WNK4 on ROMK channels. The interaction among WNK4, SFK and SGK1 plays an important role in stimulating K secretion during increasing K intake and in preventing K loss during volume depletion. However, the molecular mechanism by which c-Src modulates the interaction of SGK1 with WNK4 is not understood. The goal of the present proposal is to test the hypothesis that SFK-mediated phosphorylation of WNK4 activates protein phosphatase 1 (PP1) thereby abolishing the SGK1-induced stimulation of WNK4 phosphorylation and restoring the inhibitory effect of WNK4 on ROMK1. Specific Aim 1 is to test the hypothesis that c-Src binds and phosphorylates WNK4 and that the Tyr phosphorylation of WNK4 abolishes SGK1-induced phosphorylation at WNK4's switch domain thereby locking WNK4 in inhibitory mode for ROMK. Specific Aim 2 is to test the hypothesis that PP1 binds to WNK4 and is involved in mediating the effect of c-Src on WNK4-induced inhibition of ROMK. Specific Aim 3 is to test the hypothesis that PTP1D binds to WNK4, modulates PP1 activity and participates in the interaction among SGK1, WNK4 and c- Src, a mechanism which specifically regulates ROMK but has no effect on ENaC. The significance of the project is to expand the current understanding regarding the regulation of Na and K transport in the ASDN and to provide an integrated mechanism of WNK4-mediated regulation of ROMK in the ASDN.
描述(由申请人提供):withno - lysine Kinase 4 (WNK4)在醛固酮敏感远端肾元(ASDN)中调节Na和K转运中起重要作用。WNK4突变导致家族性高钾血症高血压,这是一种常染色体显性疾病,以盐敏感性高血压、高钾血症和肾小管酸中毒为特征(假性低醛固酮症II型)。大量证据表明,WNK4抑制ROMK,调节ENaC并调节集管中细胞旁Cl的通透性。血清糖皮质激素诱导的激酶1 (SGK1)介导的WNK4“开关结构域”磷酸化可减弱WNK4对ROMK的抑制作用。最近,我们进一步证明了src家族蛋白酪氨酸激酶(SFK),如c-Src,磷酸化WNK4,并减少sgk1诱导的WNK4磷酸化,从而恢复WNK4对ROMK通道的抑制作用。WNK4、SFK和SGK1之间的相互作用在增加K摄入量时刺激K分泌和在体积消耗时防止K损失中起重要作用。然而,c-Src调节SGK1与WNK4相互作用的分子机制尚不清楚。本研究的目的是验证sfk介导的WNK4磷酸化激活蛋白磷酸酶1 (PP1)的假设,从而消除sgk1诱导的WNK4磷酸化刺激,恢复WNK4对ROMK1的抑制作用。具体目的1是验证c-Src结合并磷酸化WNK4的假设,以及WNK4的Tyr磷酸化消除了sgk1诱导的WNK4开关结构域的磷酸化,从而将WNK4锁定在ROMK的抑制模式。特异性目的2是验证PP1与WNK4结合并参与介导c-Src对WNK4诱导的ROMK抑制作用的假设。特异性目的3是验证PTP1D结合WNK4,调节PP1活性,参与SGK1、WNK4和c- Src之间相互作用的假设,该机制特异性调节ROMK,但对ENaC没有影响。本项目的意义在于扩大目前对ASDN中Na和K转运调控的认识,并提供wnk4介导的ASDN中ROMK调控的综合机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wenhui Wang其他文献

Wenhui Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wenhui Wang', 18)}}的其他基金

Epoxyeicosatrienoic Acids Regulate Na Transport in CCD
环氧二十碳三烯酸调节 CCD 中的钠离子传输
  • 批准号:
    7137831
  • 财政年份:
    2005
  • 资助金额:
    $ 35.02万
  • 项目类别:
REGULATION OF MTAL FUNCTION BY 20-HETE, NO, AND CO
20-HETE、NO 和 CO 对 MTAL 功能的调节
  • 批准号:
    6796315
  • 财政年份:
    2003
  • 资助金额:
    $ 35.02万
  • 项目类别:
REGULATION OF MTAL FUNCTION BY 20-HETE, NO, AND CO
20-HETE、NO 和 CO 对 MTAL 功能的调节
  • 批准号:
    6653344
  • 财政年份:
    2002
  • 资助金额:
    $ 35.02万
  • 项目类别:
MODULATION AND REGULATION OF ROMK CHANNELS IN KIDNEY
肾脏 ROMK 通道的调节和调节
  • 批准号:
    6285695
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
Modulation and Regulation of ROMK Channels in Kidney
肾脏 ROMK 通道的调节和调节
  • 批准号:
    8108244
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
Modulation and Regulation of ROMK Channels in Kidney
肾脏 ROMK 通道的调节和调节
  • 批准号:
    7486203
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
MODULATION AND REGULATION OF ROMK CHANNELS IN KIDNEY
肾脏 ROMK 通道的调节和调节
  • 批准号:
    6635131
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
REGULATION OF MTAL FUNCTION BY 20-HETE, NO, AND CO
20-HETE、NO 和 CO 对 MTAL 功能的调节
  • 批准号:
    6578855
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
MODULATION AND REGULATION OF ROMK CHANNELS IN KIDNEY
肾脏 ROMK 通道的调节和调节
  • 批准号:
    6846526
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:
MODULATION AND REGULATION OF ROMK CHANNELS IN KIDNEY
肾脏 ROMK 通道的调节和调节
  • 批准号:
    6558485
  • 财政年份:
    2001
  • 资助金额:
    $ 35.02万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 35.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了